VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $250 | -34.6% | 58,000 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $382 | -64.9% | 58,000 | -63.9% | 0.00% | 0.0% |
| Q1 2023 | $1,089 | +175.7% | 160,500 | +200.0% | 0.00% | 0.0% |
| Q4 2022 | $395 | -99.9% | 53,500 | +17.3% | 0.00% | 0.0% |
| Q3 2022 | $450,000 | -9.5% | 45,600 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $497,000 | +2.3% | 45,600 | +6.0% | 0.00% | 0.0% |
| Q1 2022 | $486,000 | +71.7% | 43,000 | +137.6% | 0.00% | +100.0% |
| Q4 2021 | $283,000 | -12.1% | 18,100 | -3.7% | 0.00% | 0.0% |
| Q3 2021 | $322,000 | -20.3% | 18,800 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $404,000 | +58.4% | 18,800 | +10.6% | 0.00% | 0.0% |
| Q1 2021 | $255,000 | -38.1% | 17,000 | -45.9% | 0.00% | -50.0% |
| Q4 2020 | $412,000 | -32.8% | 31,400 | -50.6% | 0.00% | -33.3% |
| Q3 2020 | $613,000 | +2.9% | 63,500 | +21.9% | 0.00% | 0.0% |
| Q2 2020 | $596,000 | -0.8% | 52,100 | -10.3% | 0.00% | 0.0% |
| Q1 2020 | $601,000 | -20.5% | 58,100 | +26.0% | 0.00% | 0.0% |
| Q4 2019 | $756,000 | -45.5% | 46,100 | -55.8% | 0.00% | 0.0% |
| Q3 2019 | $1,386,000 | +93.8% | 104,400 | +105.5% | 0.00% | 0.0% |
| Q2 2019 | $715,000 | -8.6% | 50,800 | +19.5% | 0.00% | -25.0% |
| Q1 2019 | $782,000 | -9.5% | 42,500 | +28.4% | 0.00% | 0.0% |
| Q4 2018 | $864,000 | -8.1% | 33,100 | -19.3% | 0.00% | 0.0% |
| Q3 2018 | $940,000 | +4.0% | 41,000 | -13.7% | 0.00% | 0.0% |
| Q2 2018 | $904,000 | +24.0% | 47,500 | +9.7% | 0.00% | +33.3% |
| Q1 2018 | $729,000 | -14.6% | 43,300 | -23.0% | 0.00% | -25.0% |
| Q4 2017 | $854,000 | +8.2% | 56,200 | +27.4% | 0.00% | +33.3% |
| Q3 2017 | $789,000 | +0.9% | 44,100 | -8.1% | 0.00% | 0.0% |
| Q2 2017 | $782,000 | +12.7% | 48,000 | -3.2% | 0.00% | 0.0% |
| Q1 2017 | $694,000 | -8.2% | 49,600 | +4.6% | 0.00% | 0.0% |
| Q4 2016 | $756,000 | +2.9% | 47,400 | +7.2% | 0.00% | 0.0% |
| Q3 2016 | $735,000 | +6.5% | 44,200 | -28.4% | 0.00% | 0.0% |
| Q2 2016 | $690,000 | +7.8% | 61,700 | -19.5% | 0.00% | 0.0% |
| Q1 2016 | $640,000 | – | 76,627 | – | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2014 | $861,000 | -35.7% | 60,100 | -53.4% | 0.00% | +33.3% |
| Q3 2014 | $1,340,000 | +249.9% | 129,000 | +444.3% | 0.00% | +50.0% |
| Q2 2014 | $383,000 | +6.7% | 23,700 | +7.2% | 0.00% | 0.0% |
| Q1 2014 | $359,000 | +66.2% | 22,100 | +27.0% | 0.00% | +100.0% |
| Q4 2013 | $216,000 | +1.4% | 17,400 | -10.3% | 0.00% | 0.0% |
| Q3 2013 | $213,000 | +195.8% | 19,400 | +118.0% | 0.00% | – |
| Q2 2013 | $72,000 | – | 8,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |